PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2006 March; 7(1): E29–E32.
Published online 2006 January 13. doi:  10.1208/pt070104
PMCID: PMC2750711

Determination of aqueous solubility by heating and equilibration: A technical note

Summary and Conclusion

A modified shake-flask solubility method, where the equilibration time was shortened through heating, was used to determine the solubility of 48 different drugs and pharmaceutical excipients in pure water at room temperature. The heating process accelerates dissolution of the solid compound and frequently results in supersaturated solution. Seeding with the solid compound after heating and cooling to room temperature promotes precipitation of the solid compound in its original stable form. This modified shake-flask method generates reliable and reproducible solubility data.

Keywords: solubility, solubility determination, shake-flask method

Full Text

The Full Text of this article is available as a PDF (71K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–420. doi: 10.1023/A:1016212804288. [PubMed] [Cross Ref]
2. Lipinski CA. Drug-like properties and the cause of poor solubility and poor permeability. J Pharmacol Toxicol Methods. 2000;44:235–249. doi: 10.1016/S1056-8719(00)00107-6. [PubMed] [Cross Ref]
3. Dehring KA, Workman HL, Miller KD, Mandagere A, Poole SK. Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility. J Pharm Biomed Anal. 2004;36:447–456. doi: 10.1016/j.jpba.2004.07.022. [PubMed] [Cross Ref]
4. Bergström CAS, Norinder U, Luthman K, Artursson P. Experimental and computational screening models for prediction of aqueous solubility. Pharm Res. 2002;19:182–188. doi: 10.1023/A:1014224900524. [PubMed] [Cross Ref]
5. Glomme A, März J, Dressman JB. Comparison of a miniaturized shaken-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. J Pharm Sci. 2005;94:1–16. doi: 10.1002/jps.20212. [PubMed] [Cross Ref]
6. Yalkowsky SH. Solubility and Solubilization in Aqueous Media. Washington, DC: Am Chem Soc; 1999.
7. Delaney JS. Predicting aqueous solubility from structure. Drug Discov Today. 2005;10:289–295. doi: 10.1016/S1359-6446(04)03365-3. [PubMed] [Cross Ref]
8. Bergström CA. In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption. Basic Clin Pharmacol Toxicol. 2005;96:156–161. doi: 10.1111/j.1742-7843.2005.pto960303.x. [PubMed] [Cross Ref]
9. Loftsson T, Hreinsdóttir D, Másson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm. 2005;302:18–28. doi: 10.1016/j.ijpharm.2005.05.042. [PubMed] [Cross Ref]
10. Pitha J, Milecki J, Fales H, Pannell L, Uekama K. Hydroxypropyl-β-cyclodextrin: preparation and characterization; effects on solubility of drugs. Int J Pharm. 1986;29:73–82. doi: 10.1016/0378-5173(86)90201-2. [Cross Ref]
11. Rasool AA, Hussain AA, Dittert LW. Solubility enhancement of some water-insoluble drugs in the presence of nicotinamide and related compounds. J Pharm Sci. 1991;80:387–393. doi: 10.1002/jps.2600800422. [PubMed] [Cross Ref]
12. Connors KA, Amidon BL, Stella VJ. Chemical Stability of Pharmaceuticals. New York, NY: John Wiley & Sons; 1986.
13. Kabasakalian P, Britt E, Yudis MD. Solubility of some steroids in water. J Pharm Sci. 1966;55:642–642. doi: 10.1002/jps.2600550625. [PubMed] [Cross Ref]
14. Rowe RC, Sheskey PJ, Weller PJ, editors. Handbook of Pharmaceutical Excipients. London, UK: Pharmaceutical Press; 2003.
15. Moffat AC, Osselton MD, Widdop B, editors. Clarke’s Analysis of Drugs and Poisons. 3rd ed. London, UK: Pharmaceutical Press; 2004.
16. maren TH, Conroy CW. A new class of carbonic anhydrase inhibitor. J Biol Chem. 1993;268:26233–26239. [PubMed]
17. Murphy D, Rodrídues-Cintrón F, Langevin B, Kelly RC, Rodrígues-Hornedo N. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. Int J Pharm. 2002;246:121–134. doi: 10.1016/S0378-5173(02)00358-7. [PubMed] [Cross Ref]
18. Chen X-Q, Venkatesh S. Miniature device for aqueous and non-aqueous solubility measurements during drug disovery. Pharm Res. 2004;21:1758–1761. doi: 10.1023/B:PHAM.0000045225.76650.53. [PubMed] [Cross Ref]
19. Ohno K, Azuma Y, Date K, et al. Evaluation of styrene oligomers eluted from polystyrene for estrogenicity in estrogen receptor binding assay, receptor gen assay, and uterotrophic assay. Food Chem Toxicol. 2003;41:131–141. doi: 10.1016/S0278-6915(02)00211-9. [PubMed] [Cross Ref]
20. Jain N, Yalkowsky SE. Estimation of the aqueous solubility. I. application to organic nonelectrolytes. J Pharm Sci. 2001;90:234–252. doi: 10.1002/1520-6017(200102)90:2<234::AID-JPS14>3.0.CO;2-V. [PubMed] [Cross Ref]
21. Bergström CAS, Luthman K, Artursson P. Accuracy of calculated pH-dependent aqueous drug solubility. Eur J Pharm Sci. 2004;22:387–398. doi: 10.1016/j.ejps.2004.04.006. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists